Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
Gameto Announces New Funding and Preclinical Development Partnerships with Leading Global Fertility Clinics
Gameto, a biotechnology company using cell engineering to develop therapeutics for diseases of the female […]
Debiopharm Co-leads a 10M USD Series A Round to Accelerate the Development of Genomic Medicines through Artificial Intelligence
Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm (www.Debiopharm.com), announced today […]
Neurolens Raises $67 Million from MVM Partners, Falcon Vision/KKR, Marshall Wace & Existing Investors
Neurolens, a company commercializing innovative solutions to optimize vision, today announced completion of a $67 million financing. […]
Redbud Raises $10M in Series A Round as CRO Focusing on Science-driven Clinical Development
Redbud Medicine, the Delaware-headquartered contract research organization (CRO) announced on Monday following the completion of a series […]
Elephas Announces $41.5 Million in Series B Funding
Elephas Biosciences Corporation (Elephas), a private company, announced today that it has raised $41.5 million in Series […]
Upfront Raises $10.5 Million in Oversubscribed Series C; Unveils Advanced Product Features
Patient engagement and access platform Upfront today announced an additional $10.5 million in funding to accelerate its growth and […]
Pleco Therapeutics Announces Final Close of its Series A Financing Raising €17.3m to Progress its Novel Plecoid™ Product in Acute Myeloid Leukaemia to Regulatory Filing in USA and EU
Pleco Therapeutics BV, a specialty biopharmaceutical company developing novel treatments designed to detoxify the cancer […]
Neukio Biotherapeutics Completed Series A-1 Financing, to Accelerate Discovery and Development of Next Generation Cell Therapy Products
Neukio Biotherapeutics, a company committed to developing novel cell therapy products, announces it has closed $50 […]
Avails Medical Awarded Additional $1.7m in CARB-x Funding for the Development of Its Rapid Antibiotic Susceptibility Testing Device to Identify the Most Effective Antibiotic Therapy
Avails Medical, a pioneer in rapid, automated, and fully electrical antibiotic susceptibility testing (eAST™) announced […]
Insightec Announces Financing up to $200 Million to Fund Continued Growth
Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, today […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more